A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status
Titel:
A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status
Auteur:
Cobo, Manuel Gutiérrez, Vanesa Alcaide, Julia Alés, Inmaculada Villar, Esther Gil, Silvia Durán, Gema Martínez, Joaquina Carabantes, Francisco Bretón, Juan J. Benavides, Manuel